Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 26:10.14309/ajg.0000000000003427.
doi: 10.14309/ajg.0000000000003427. Online ahead of print.

Prevention of Alcohol-Associated Liver Disease

Affiliations

Prevention of Alcohol-Associated Liver Disease

Robyn Burton et al. Am J Gastroenterol. .

Abstract

Alcohol-associated liver disease (ALD) is the leading cause of morbidity, disease-adjusted life years lost, and mortality worldwide. The significant burden and cost to the healthcare systems from ALD are largely preventable, given that alcohol use is the most important determinant of risk and severity of ALD. In this article, we will review the emerging evidence for public health policies (minimum unit price of alcohol, limiting, or banning alcohol advertising), aiming to reduce the availability of alcohol at the population level (primary prevention), preventing ALD especially advanced form of cirrhosis in at-risk individuals (secondary prevention), and improving liver outcomes and long-term survival in patients with advanced ALD of cirrhosis and/or alcohol-associated hepatitis (tertiary prevention). We will highlight the critical role of clinicians in promoting the public health policies, widespread screening for alcohol use disorder and for ALD, and integrating liver with addiction care for patients with ALD.

Keywords: ALD; MUP; integrated; policy; screening.

PubMed Disclaimer

References

    1. Singal AK, Mathurin P. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review. JAMA 2021; 326(2): 165–76. - PubMed
    1. Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol 2018; 113(2): 175–94. - PMC - PubMed
    1. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023; 78(6): 1966–86. - PMC - PubMed
    1. Collaborators GBDC. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020; 5(3): 245–66. - PMC - PubMed
    1. Wong RJ, Singal AK. Trends in Liver Disease Etiology Among Adults Awaiting Liver Transplantation in the United States, 2014–2019. JAMA Netw Open 2020; 3(2): e1920294. - PMC - PubMed

LinkOut - more resources